Last Updated On 3/31/2024 11:30:35 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| Company: Merck |
| Recipient: You |
| Company: Johnson & Johnson |
| Recipient: You |
|
| Honoraria |
| Company: Novocure |
| Recipient: You |
| Company: Astra Zeneca |
| Recipient: You |
| Company: Janssen Oncology |
| Recipient: You |
| Company: Takeda |
| Recipient: You |
| Company: Blueprint Medicines |
| Recipient: You |
| Company: ThermoFisher |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: AstraZeneca |
| Recipient: You |
| Company: Ikena Oncology |
| Recipient: You |
| Company: Bristol-Myers Squibb/Celgene |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: Janssen Oncology |
| Recipient: You |
| Company: Regeneron |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Lilly |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Janssen Oncology |
| Recipient: Your Institution |
| Company: Ikena Oncology |
| Recipient: Your Institution |
| Company: Genentech |
| Recipient: Your Institution |
| Company: Merck |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| Company: Regeneron |
| Recipient: You |
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
|
| Open Payments URL: https://openpaymentsdata.cms.gov/physician/856967 |
|